Overview of Doloflex Relax

Doloflex Relax is a specialized Fixed-Dose Combination (FDC) medicine, typically manufactured as an oral preparation like a tablet, developed for the simultaneous relief of multifaceted musculoskeletal discomfort. The multi-component drug structure integrates four distinct active ingredients, positioning it as a comprehensive approach to managing pain, inflammation, and muscle spasm.

Quick Facts

Property	Description
Active Ingredients	Aluminium Hydroxide, Carisoprodol, Ketoprofen, Paracetamol
Form	Oral Tablet (Fixed-Dose Combination)
Pharmacological Class	Analgesic, NSAID, Skeletal Muscle Relaxant, Antacid
Common Use (General)	Symptomatic relief of pain, inflammation, and muscle spasm
Origin	Synthetic, generally supplied as a prescription-only medicine (Rx)

Pharmacological Classification and Key Active Ingredients

This medicine belongs to four distinct pharmacological classes due to its complex composition: it acts simultaneously as an Analgesic, a Nonsteroidal Anti-inflammatory Drug (NSAID), a Skeletal Muscle Relaxant, and an Antacid. The formulation strategically combines the potent anti-inflammatory action of Ketoprofen with the complementary pain relief and antipyresis of Paracetamol (Acetaminophen). The inclusion of Carisoprodol, a centrally acting muscle relaxant, acts to ease acute muscle spasms. This unique combination is intended to address both the pain and the underlying tension that often co-occur in acute musculoskeletal events.

General Purpose and Synergistic Action

The general purpose of Doloflex Relax is to provide comprehensive symptomatic relief by leveraging its synergistic components. Unlike simpler formulations that might only target inflammation or pain, the FDC is designed to break the pain-spasm cycle. The combined effect of strong anti-inflammation and analgesia paired with the spasmolysis provided by the muscle relaxant offers a unified solution for managing the pain, tension, and inflammatory components of musculoskeletal discomfort. The presence of Aluminium Hydroxide serves an auxiliary role by neutralizing gastric acid, which mitigates potential gastrointestinal discomfort commonly associated with NSAIDs like Ketoprofen.

Regulatory References

Therapeutic Uses of Doloflex Relax

What Doloflex Relax Treats: Main Uses and Benefits

Doloflex Relax is considered relevant in contexts marked by increased discomfort or tension, addressing symptoms of increased muscular activity, tension, and stiffness often associated with acute, painful musculoskeletal conditions. It is relevant when supportive symptom management is appropriate, and may be part of symptomatic management for symptoms related to physical discomfort.

The medication is commonly used to help address symptoms related to inflammatory or irritative states and localized discomfort resulting from acute episodes, providing supportive relief when symptoms interfere with routine activities. It is relevant for easing recurrent or episodic manifestations of low back pain (lumbago), symptoms that may accompany sciatica, and muscle stiffness following strains or sprains.

“It is used when symptoms create noticeable physiological strain, offering symptomatic relief that helps patients cope more steadily with difficult episodes.”

Quick Fact: Symptomatic support for acute muscle and joint discomfort

When symptoms intensify and supportive relief is needed, the medication contributes to easing the overall symptom load and may assist with maintaining functional stability during difficult episodes.

Eligibility and Restrictions for Use

Who Can and Cannot Use Doloflex Relax?

Eligibility for Doloflex Relax is strictly determined by regulatory labeling, primarily due to the inclusion of an NSAID (Ketoprofen) and a skeletal muscle relaxant (Carisoprodol).

Contraindicated Populations (Must Not Use)

Use is contraindicated for patients with a known allergy to any component, including a history of asthma, hives, or allergic reactions after taking aspirin or other NSAIDs. The medicine must not be used by individuals with active peptic ulcers, recurrent gastrointestinal bleeding, or severe uncontrolled heart, kidney, or liver impairment. Use is also strictly prohibited during the third trimester of pregnancy and in patients with acute intermittent porphyria.

Populations with Restricted or Limited Use

Official labeling defines several groups requiring conditional use or heightened caution. Older adults are advised to use the medication with caution due to an increased risk of adverse reactions. Similarly, patients with mild to moderate hepatic or renal impairment may only be eligible under specific regulatory conditions. The safety and effectiveness of Doloflex Relax have not been established in pediatric patients (under 16 or 18 years of age), and use is not recommended during breastfeeding or the first and second trimesters of pregnancy.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This fixed-dose combination necessitates strict consideration of officially documented interaction patterns across its components. Co-administration is formally contraindicated with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and any other Paracetamol-containing products to mitigate risks of toxicological duplication. The muscle relaxant component, Carisoprodol, is officially documented to have additive sedative effects with substances classified as Central Nervous System (CNS) depressants, including alcohol and opioid medicines.

The NSAID component, Ketoprofen, presents clinically significant risks when combined with agents that affect blood clotting, such as anticoagulants, enhancing the potential for bleeding. Furthermore, combining Ketoprofen with ACE Inhibitors, ARBs, or Diuretics increases the documented risk of renal decompensation.

Pharmacokinetic interactions are also officially noted. The metabolism of Carisoprodol is altered by specific CYP2C19 inhibitors and inducers, leading to changes in systemic exposure. The antacid component, Aluminium Hydroxide, reduces the systemic absorption of multiple drugs, including Tetracyclines and Digoxin, a constraint that often requires administration separation of two to three hours to mitigate absorption interference. The toxicity risk of Paracetamol is formally increased by co-use with liver enzyme inducers and chronic alcohol consumption. This profile establishes constraints based on pharmacodynamic reinforcement and strict pharmacokinetic requirements.

Mechanism of Action

Doloflex Relax is a combination product typically containing a centrally-acting skeletal muscle relaxant, an NSAID, and an analgesic/antipyretic. The muscle relaxant component, often chlorzoxazone or cyclobenzaprine, modulates central nervous system activity primarily at the brainstem level. Cyclobenzaprine acts as an antagonist at multiple receptor targets, including serotonin 5-HT2 and alpha1-adrenergic receptors, and exhibits non-competitive antagonism at histamine H1 receptors. These interactions modify descending noradrenergic and serotonergic pathways. The resulting cascade includes diminished efferent alpha and gamma motor neuron activity, mediated via inhibition of reticulospinal or coeruleus-spinal tracts, leading to a depression of spinal cord interneuron activity. The system-level consequence is a reduction in skeletal muscle hypertonia and associated reflexive hyperactivity.

Concurrently, the NSAID component, often aceclofenac, acts as an inhibitor of the cyclo-oxygenase (COX) enzymes, specifically COX-1 and COX-2. This inhibition blocks the conversion of arachidonic acid into prostaglandins, which are local mediators of cellular signaling. The analgesic component, typically paracetamol (acetaminophen), exerts its primary action centrally, often via the inhibition of CNS-specific COX isoforms and modulation of descending serotonergic pathways, contributing to central nociceptive signal attenuation.

Dosage and Administration Information

How to Use Doloflex Relax

This section describes the administration protocol for Doloflex Relax as established for fixed-dose combination (FDC) medicines containing analgesics, NSAIDs, and muscle relaxants.

Administration Scope

The medicine is designated solely for oral administration as a fixed-dose combination tablet. The standard regimen for an adult patient involves taking one tablet per dose, with the maximum daily intake being four tablets per day. To comply with safety and absorption guidelines, a minimum time interval of four to six hours must be maintained between subsequent doses.

The tablet must be swallowed whole without being crushed or divided, and administration is required with or immediately following food. This requirement addresses potential gastrointestinal irritation associated with the nonsteroidal anti-inflammatory component, Ketoprofen.

Usage Constraints and Duration

Doloflex Relax is restricted to short-term use only for the symptomatic management of acute musculoskeletal discomfort. The overall duration of any single treatment course must not exceed a limit, typically 14 days. This constraint is necessary due to the profile of the muscle relaxant component, Carisoprodol.

Special procedural conditions apply to specific populations. A dose reduction or adjusted frequency is utilized for older adult patients. Furthermore, dosage adjustment is required for patients with documented hepatic or renal impairment, reflecting the metabolism of Paracetamol and elimination of Ketoprofen.

If a dose is missed and the time for the next scheduled dose is imminent, the missed dose should be skipped to maintain the mandated four-to-six-hour interval.

Recent Clinical Evidence

Research evidence / Overview of studies for Doloflex Relax

The research base for this medicine is primarily composed of short-term Randomized Controlled Trials (RCTs) and systematic reviews that have studied the individual therapeutic components, specifically the skeletal muscle relaxant (Carisoprodol) and the analgesic/NSAID combination. These trials were designed to explore symptom patterns associated with acute low back pain and muscle spasm in adult populations, typically those experiencing symptoms for less than three weeks. Outcomes evaluated included measurements of pain intensity on standardized scales and patient-reported functional ability.

Studies monitoring acute symptom activity generally concluded within seven to fourteen days. Findings describe patterns of change observed in these measured outcomes over short time intervals. The evidence is also derived from trials on the analgesic and anti-inflammatory components used in research exploring localized discomfort from acute musculoskeletal injury (strains and sprains), with data often extrapolated from general acute pain studies. Research exploring symptom changes was primarily conducted over defined time intervals that were short in duration, meaning long-term effects are not fully established and data are still emerging regarding repeated or sustained use of this medicine.

Results generally apply only to the populations studied, which were overwhelmingly healthy adults under the age of 65. Data for certain groups remain insufficient, as there is a notable absence of dedicated trials for children, older adults (generally over 70), or individuals with pre-existing organ impairment. Furthermore, comparative evidence is lacking for the specific four-component fixed-dose combination against established two- or three-component therapies. Therefore, certainty remains low regarding the specific contribution of this precise formulation, and evidence quality varies across studies.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Doloflex Relax (FAQ)

Q: How quickly does Doloflex Relax typically start working for muscle pain?

Official product information for the muscle relaxant component suggests effects generally begin within 30 minutes after taking the tablet. The overall duration of action should be considered when planning subsequent doses.

Q: How long does the pain relief effect of Doloflex Relax usually last?

Regulatory information suggests the effects of the muscle relaxant component generally last for 4 to 6 hours. This timeframe dictates the minimum interval that is recommended between doses.

Q: Is it okay to drive or operate machinery after taking this medication?

Regulatory labeling indicates that the medicine may impair the mental and physical abilities required for potentially hazardous tasks, such as driving a motor vehicle or operating machinery, due to its sedative properties. Use caution until you know how the medicine affects you.

Q: Does taking Doloflex Relax with food help reduce side effects?

Yes. This administration method is required to help mitigate the potential for gastrointestinal irritation associated with the Nonsteroidal Anti-inflammatory Drug (NSAID) component, as directed in the prescribing information.

Q: Can I take Doloflex Relax if I'm taking other medicines for anxiety or sleep?

Official information indicates that this medicine has additive sedative effects when combined with other Central Nervous System (CNS) depressants. This class includes many medicines used for anxiety or sleep, and combining them may result in an increased sedative effect.

Q: Does Doloflex Relax have any anti-inflammatory properties?

Yes, Doloflex Relax includes a Nonsteroidal Anti-inflammatory Drug (NSAID) component, Ketoprofen. This ingredient works by inhibiting COX enzymes, a mechanism associated with anti-inflammatory action.

Q: Is there a risk of withdrawal symptoms if I stop taking Doloflex Relax suddenly?

Official regulatory labeling notes that abrupt cessation, particularly after prolonged use, has been associated with a risk of dependence and withdrawal symptoms. Reported symptoms may include insomnia, headache, and tremors.

Q: Is it normal to feel a little dizzy when first starting Doloflex Relax?

Dizziness is documented as a common adverse reaction in the official safety profile. Regulatory information notes the sedative properties of the muscle relaxant component may be more frequently observed at the start of treatment.

Q: Why do some users report stomach issues after taking Doloflex Relax?

Gastrointestinal discomforts, such as nausea and indigestion (dyspepsia), are common side effects listed for the NSAID and analgesic components. These ingredients can cause irritation to the lining of the stomach. The prescribing information mandates administration with food to help address this potential discomfort.

Q: Is Doloflex Relax used for nerve pain, or only for muscle and joint pain?

The medicine is indicated for the relief of discomfort related to acute, painful musculoskeletal conditions, including muscle and joint pain. Its specific use for nerve pain has not been established in the core product labeling.

Q: What kind of studies have been done on the effectiveness of Doloflex Relax?

Research evidence for this combination product is primarily derived from short-term Randomized Controlled Trials (RCTs) and systematic reviews. These studies focus on the effectiveness of the individual therapeutic components in managing acute musculoskeletal pain.

Q: Is it normal to have a slight headache when starting this medication?

Yes, headache is listed as a commonly reported adverse reaction in the safety profiles for both the muscle relaxant component and the NSAID component of this medicine.

Q: Can children or teenagers use Doloflex Relax for injuries?

The safety and effectiveness of this medicine have not been established in pediatric patients, typically those under the age of 16 or 18. Due to the lack of established data, official regulatory documents state that use is not recommended for this pediatric population.

Q: Are there any dietary restrictions I should follow while using Doloflex Relax?

The official label mandates taking the tablet with or immediately following food. Beyond this specific instruction, there are no other general dietary restrictions specified in the prescribing information.

Q: Does Doloflex Relax interact with oral contraceptives?

Regulatory information indicates that the NSAID component (Ketoprofen) has been documented to potentially interact with hormonal contraceptives.

Q: Is Doloflex Relax safe to take with common cold or flu medicines?

Official drug interaction warnings state that co-administration is forbidden with any other Paracetamol-containing products or NSAIDs, as many common cold and flu medicines contain these ingredients.

Q: What are the signs of taking too much Doloflex Relax?

Signs of overdosage primarily related to the muscle relaxant component may include Central Nervous System (CNS) depression, confusion, respiratory depression, seizures, and hallucinations. Suspected overdose requires immediate medical attention.

Q: Can taking Doloflex Relax cause constipation or diarrhea?

Yes, both constipation and diarrhea are listed as common gastrointestinal side effects associated with the Nonsteroidal Anti-inflammatory Drug (NSAID) component of this combination medicine.

Q: Why is the paracetamol component included in Doloflex Relax?

The Paracetamol component is included to provide complementary pain relief (analgesia) and to act as an antipyretic (fever reducer). This leverages its central mechanism of action to enhance the overall symptom relief provided by the fixed-dose combination.

How should Doloflex Relax be stored and disposed of?

The official regulatory requirements for storing and disposing of Doloflex Relax tablets are based on universal guidelines for oral prescription medication.

Mandatory Storage and Protection

The tablets must be stored at Controlled Room Temperature, typically defined as 20 C to 25 C (68 F to 77 F). The product must be kept in its original, tightly closed container and protected from both light and excessive moisture to maintain its required stability. The medicine must not be frozen and should be stored out of the sight and reach of children.

Disposal Instructions

Unused or expired Doloflex Relax must not be disposed of in household trash or down a sink/toilet unless specifically instructed otherwise by the product label. Disposal must be performed through an official medicine take-back program or at a designated collection point, according to local pharmaceutical waste regulations.

Category	Regulatory Safety Statement
Frequency-Classified Reactions	Common reactions often include Drowsiness/Sedation, Dizziness, and Gastrointestinal discomforts such as dyspepsia and nausea. Severe events are classified as Rare occurrences.
System-Organ Classes	Adverse reactions are documented across several physiological systems, including Nervous System Disorders, Gastrointestinal Disorders, Hepatobiliary Disorders, and Skin and Subcutaneous Tissue Disorders.
Serious Adverse Reactions	Regulatory documents explicitly list the potential for Serious Gastrointestinal Bleeding, Ulceration, or Perforation (NSAID component) and Hepatotoxicity or Acute Liver Failure (Paracetamol component) as serious risks.

Doloflex Relax